Medicenna Therapeutics Corp.
MDNAF
$0.56
$0.012.01%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -9.41M | -9.99M | -9.50M | -8.59M | -19.73M |
| Total Depreciation and Amortization | 55.10K | 56.50K | 47.90K | 37.90K | 25.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -5.52M | -4.18M | -4.45M | -4.20M | 8.12M |
| Change in Net Operating Assets | 1.69M | 1.94M | 1.20M | 915.90K | -364.80K |
| Cash from Operations | -13.19M | -12.17M | -12.70M | -11.84M | -11.95M |
| Capital Expenditure | 0.00 | 0.00 | -1.50K | -24.20K | -24.20K |
| Sale of Property, Plant, and Equipment | 1.40K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 1.40K | 0.00 | -1.50K | -24.20K | -24.20K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -70.00K | -51.00K | -32.00K | -19.00K | -- |
| Issuance of Common Stock | 52.00K | 1.96M | 2.97M | 23.81M | 23.81M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | -300.00K | -300.00K | -300.00K |
| Cash from Financing | -12.40K | 1.36M | 1.90M | 17.14M | 17.15M |
| Foreign Exchange rate Adjustments | -660.90K | 317.50K | -76.00K | 633.20K | 784.70K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -13.86M | -10.49M | -10.88M | 5.91M | 5.96M |